Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.06% | -4.50% | -21.26% | -26.56% | -16.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.06% | -4.50% | -21.26% | -26.56% | -16.65% |
| Cost of Revenue | 18.91% | -5.51% | -25.84% | -32.51% | -19.09% |
| Gross Profit | -7.42% | 0.66% | 4.23% | 8.86% | -3.80% |
| SG&A Expenses | -0.89% | 6.23% | 11.63% | 16.97% | 11.93% |
| Depreciation & Amortization | 39.67% | 32.13% | 24.11% | 19.72% | -33.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.04% | -2.65% | -19.92% | -25.69% | -16.69% |
| Operating Income | -216.38% | -309.89% | -182.05% | -118.51% | -13.03% |
| Income Before Tax | -295.01% | -281.71% | -354.20% | -748.14% | -46.54% |
| Income Tax Expenses | 613.02% | 360.64% | -35.04% | 91.08% | 102.88% |
| Earnings from Continuing Operations | -296.08% | -287.10% | -355.69% | -767.39% | -77.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -296.08% | -287.10% | -355.69% | -767.39% | -77.46% |
| EBIT | -216.38% | -309.89% | -182.05% | -118.51% | -13.03% |
| EBITDA | -30.80% | -16.80% | -13.12% | -7.27% | -34.16% |
| EPS Basic | -189.45% | -184.72% | -290.08% | -531.93% | -71.92% |
| Normalized Basic EPS | -49.36% | -33.27% | -27.58% | -8,052.63% | -986.00% |
| EPS Diluted | -189.45% | -184.72% | -290.08% | -531.93% | -71.92% |
| Normalized Diluted EPS | -49.36% | -33.27% | -27.58% | -8,052.63% | -986.00% |
| Average Basic Shares Outstanding | -2.43% | -2.38% | -1.40% | -0.40% | 0.66% |
| Average Diluted Shares Outstanding | -2.43% | -2.38% | -1.40% | -0.40% | 0.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.00% | 0.97% | 0.93% | 0.94% | 0.56% |